Latest & Greatest

Latest & Greatest

Recent developments in the field of hematology/oncology, including drug approvals, policy updates, and clinical trial results

NIH Releases New Requirements for Fetal Tissue Research Funding

The National Institutes of Health (NIH) revised its grant application guidance for researchers planning to use fetal tissue, requiring that researchers comply with the...

FDA Requires Boxed Warning for Tofacitinib

The U.S. Food and Drug Administration (FDA) has issued a Safety Announcement for the Janus kinase (JAK) inhibitor tofacitinib, after finding that patients taking...
Blood donation

Facebook Unveils U.S. Blood Donation Tool

Facebook has launched a blood donation feature on its U.S. platform to connect its users to donation centers in their neighborhoods and facilitate notifications...

Scientists Develop DNA Microscope to See as the Cell Sees

Researchers at the Massachusetts Institute of Technology and Harvard University have developed a technique allowing them to see the exact order of nucleotides within...

WHO Updates List of Essential Medicines and Diagnostic Tests

The World Health Organization (WHO) has added several new cancer drugs and diagnostics to the list of medicines and tests that it considers “essential”...

CMS Increases Payment, Access to CAR T-Cell Therapy

The Centers for Medicare and Medicaid Services (CMS) announced two policy changes that should improve access to chimeric antigen receptor (CAR) T-cell therapies: First,...

Textured Breast Implants Recalled by FDA Over Cancer Risk

The U.S. Food and Drug Administration (FDA) has requested that pharmaceutical company Allergan recall its BIOCELL textured breast implants due to a risk of...

Bluebird Bio Wins European Approval for Beta Thalassemia Gene Therapy

Bluebird Bio’s one-time gene therapy, Zynteglo, has been cleared by E.U. regulators for the treatment of beta thalassemia in patients aged 12 and older....

Opioid Manufacturer Insys Therapeutics Files for Bankruptcy

Insys Therapeutics filed for Chapter 11 bankruptcy protection on June 10, just days after reaching a $225 million settlement with the U.S. Department of...

FDA Launches Call Center for Compassionate-Use Requests

The FDA has launched a call center to field doctors’ requests for access to experimental cancer drugs for individual patients who have run out...
Advertisement

Current Issue

September 2019 Volume 5 Issue 11

September 2019, Volume 5, Issue 11

This issue explores politics in the exam room, demystifies proteomic analysis in hematology, and more.